US · CTVA · AGRICULTURAL INPUTS
Corteva, Inc. (CTVA) intrinsic value and stock valuation
$7.89as of 2026-11-21 · Mkt cap 51.39B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Corteva, Inc. DCF and intrinsic value
InvestorsCraft values CTVA with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CTVA’s statements →
Corteva, Inc. Graham Number
Graham Number: $36.03d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2016–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Air Products and Chemicals, Inc. (APD) $297.09
- Vale S.A. (VALE) $9.49
- Nucor Corporation (NUE) $239.62
- Wheaton Precious Metals Corp. (WPM) $109.91
- AngloGold Ashanti plc (AU) $72.43
- Franco-Nevada Corporation (FNV) $223.21
- Vulcan Materials Company (VMC) $270.87
- Gold Fields Limited (GFI) $31.57
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $17.4B | $16.9B | $17.2B | $17.5B | $15.7B |
| Operating income | $2.62B | $2.1B | $2.11B | $1.93B | $1.32B |
| Net income | $1.09B | $907M | $735M | $1.15B | $1.76B |
| EPSd | $1.61M | $1.3M | $1.03M | $1.58M | $2.37M |
| Operating cash flow | $3.41B | $2.15B | $1.77B | $872M | $2.73B |
| Capital expenditure | -$-591M | -$-597M | -$-595M | -$-605M | -$-573M |
| Free cash flow | $2.82B | $1.55B | $1.17B | $267M | $2.15B |
| Total assets | $42.8B | $40.8B | $43B | $42.6B | $42.3B |
| Total debt | $2.58B | $2.7B | $2.49B | $1.31B | $1.12B |
| Net debt | -$-1.94B | -$-403M | -$-155M | -$-1.88B | -$-3.34B |
| Total equity | $24.4B | $24B | $25.3B | $25.5B | $25.6B |
| Cash and short-term investments | $4.53B | $3.17B | $2.74B | $3.32B | $4.55B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $17.4B | $16.9B | $17.2B | $17.5B | $15.7B |
| Cost of revenue | $9.17B | $9.53B | $9.92B | $10.4B | $9.22B |
| Gross profit | $8.23B | $7.38B | $7.31B | $7.02B | $6.44B |
| Research and development expenses | $1.47B | $1.4B | $1.34B | $1.22B | $1.19B |
| Selling, general and administrative expenses | $3.49B | $3.2B | $3.18B | $3.17B | $3.21B |
| Other expenses | $644M | $685M | $683M | $702M | $722M |
| Operating expenses | $5.61B | $5.28B | $5.2B | $5.09B | $5.12B |
| Cost and expenses | $14.8B | $14.8B | $15.1B | $15.5B | $14.3B |
| Interest income | $136M | $132M | $283M | $124M | $77M |
| Interest expense | $180M | $233M | $233M | $79M | $30M |
| Depreciation and amortization | $1.2B | $1.23B | $1.21B | $1.22B | $1.24B |
| Ebitda | $3.07B | $2.74B | $2.54B | $2.73B | $3.62B |
| Operating income | $2.62B | $2.1B | $2.11B | $1.93B | $1.32B |
| Total other income/expenses, net | -$-931M | -$-821M | -$-1.02B | -$-502M | $1.03B |
| Income before tax | $1.69B | $1.28B | $1.09B | $1.43B | $2.35B |
| Income tax expense | $484M | $412M | $152M | $210M | $524M |
| Net income | $1.09B | $907M | $735M | $1.15B | $1.76B |
| Weighted average shares outstanding | $680M | $693.7M | $709M | $720.8M | $735.9M |
| Weighted average diluted shares outstanding | $681.4M | $696M | $711.9M | $724.5M | $741.6M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.53B | $3.17B | $2.74B | $3.32B | $4.55B |
| Net receivables | $6.37B | $5.68B | $5.49B | $5.7B | $4.81B |
| Inventory | $5.67B | $5.43B | $6.9B | $6.81B | $5.18B |
| Total current assets | $17.3B | $15.1B | $16.3B | $16.8B | $15.5B |
| Property, plant and equipment, net | $4.22B | $4.1B | $4.29B | $4.25B | $4.33B |
| Goodwill and intangible assets | $18.8B | $19.3B | $20.2B | $19.3B | $20.2B |
| Long-term investments | $160M | $134M | $115M | $102M | $76M |
| Total non-current assets | $25.5B | $25.7B | $26.7B | $25.8B | $26.8B |
| Total assets | $42.8B | $40.8B | $43B | $42.6B | $42.3B |
| Accounts payable | $4.4B | $4.04B | $4.28B | $4.9B | $4.13B |
| Short-term debt | $894M | $750M | $198M | $24M | $17M |
| Deferred revenue | $3.58B | $3.29B | $3.41B | $3.39B | $3.2B |
| Total current liabilities | $12.1B | $10.4B | $10.4B | $10.7B | $9.56B |
| Long-term debt | $1.69B | $1.95B | $2.29B | $1.28B | $1.1B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | -$-3M |
| Total non-current liabilities | $6.33B | $6.41B | $7.31B | $6.33B | $7.16B |
| Capital lease obligations | $0.00 | $0.00 | $1M | $3M | $3M |
| Total liabilities | $18.5B | $16.8B | $17.7B | $17.1B | $16.7B |
| Common stock | $7M | $7M | $7M | $7M | $7M |
| Retained earnings | -$-67M | $55M | -$-41M | $250M | $524M |
| Accumulated other comprehensive income (loss) | -$-2.8B | -$-3.47B | -$-2.68B | -$-2.81B | -$-2.9B |
| Total equity | $24.4B | $24B | $25.3B | $25.5B | $25.6B |
| Total investments | $169M | $197M | $213M | $226M | $162M |
| Total debt | $2.58B | $2.7B | $2.49B | $1.31B | $1.12B |
| Net debt | -$-1.94B | -$-403M | -$-155M | -$-1.88B | -$-3.34B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $1.11B | $863M | $941M | $1.21B | $1.82B |
| Depreciation and amortization | $1.2B | $1.23B | $1.21B | $1.22B | $1.24B |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $55M | $0.00 |
| Change in working capital | $540M | -$-92M | -$-786M | -$-1.55B | $656M |
| Accounts receivable | -$-261M | -$-705M | $358M | -$-997M | -$-113M |
| Inventory | -$-35M | $1.11B | $57M | -$-1.72B | -$-422M |
| Accounts payable | $231M | -$-115M | -$-663M | $807M | $524M |
| Net cash provided by operating activities | $3.41B | $2.15B | $1.77B | $872M | $2.73B |
| Investments in property, plant and equipment | -$-591M | -$-597M | -$-595M | -$-605M | -$-573M |
| Acquisitions, net | -$-20M | -$-7M | -$-1.46B | -$-12M | -$-4M |
| Net cash used for investing activities | -$-543M | -$-589M | -$-1.99B | -$-632M | -$-362M |
| Common stock issued | $88M | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-1.07B | -$-1.01B | -$-756M | -$-1B | -$-950M |
| Dividends paid | -$-475M | -$-458M | -$-439M | -$-418M | -$-397M |
| Net cash used for financing activities | -$-1.64B | -$-1.2B | -$-99M | -$-1.18B | -$-1.27B |
| Net change in cash | $1.1B | $264M | -$-460M | -$-1.22B | $963M |
| Cash at end of period | $4.52B | $3.42B | $3.16B | $3.62B | $4.84B |
| Operating cash flow | $3.41B | $2.15B | $1.77B | $872M | $2.73B |
| Capital expenditure | -$-591M | -$-597M | -$-595M | -$-605M | -$-573M |
| Free cash flow | $2.82B | $1.55B | $1.17B | $267M | $2.15B |
Line items
Line items
Line items
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
- CEO
- Charles Magro
- Employees
- 21.5K
- Beta
- 0.56
Included in
Explore
Frequently asked questions
What is the intrinsic value of Corteva, Inc. (CTVA)?
Corteva, Inc. (CTVA) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is CTVA undervalued?
CTVA trades at a price of $7.89 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.